ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd. (603976.SS)
CNY 17.17
(-0.58%)
CNY 17.17
(-0.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 900.64 Million | 796.19 Million | 796.65 Million | 501.98 Million | 521.08 Million | 595.78 Million |
| Cost of Revenue | 756.88 Million | 629.4 Million | 592.01 Million | 373.72 Million | 379.66 Million | 424.98 Million |
| Gross Profit | 143.75 Million | 166.79 Million | 204.64 Million | 128.25 Million | 141.41 Million | 170.79 Million |
| Operating Expenses | 96.75 Million | 81.53 Million | 75.79 Million | 75.71 Million | 81.59 Million | 85.73 Million |
| Selling, General and Administrative Expenses | 23.35 Million | 22.56 Million | 28.9 Million | 40.01 Million | 43.87 Million | 48.11 Million |
| Research and Development Expenses | 23.42 Million | 19.11 Million | 12.07 Million | 8.25 Million | 5.27 Million | 2.89 Million |
| Other Expenses | 15.31 Million | 39.86 Million | 34.81 Million | 27.44 Million | 32.45 Million | -89 Thousand |
| Cost and Expenses | 855.77 Million | 710.94 Million | 667.8 Million | 449.43 Million | 461.26 Million | 510.71 Million |
| Operating Income | 44.87 Million | 93.25 Million | 122.63 Million | 61.88 Million | 71.89 Million | 94.09 Million |
| Interest Expense | 21.29 Million | 19.6 Million | 13.07 Million | 289.8 Thousand | 206.5 Thousand | 81.77 Thousand |
| Income Tax Expense | 4.55 Million | -6.21 Million | 19.36 Million | 8.32 Million | 10.28 Million | 11.24 Million |
| Earnings before Tax | 44.82 Million | 58.55 Million | 125.97 Million | 61.37 Million | 71.34 Million | 94 Million |
| Net Income | 40.26 Million | 64.77 Million | 106.6 Million | 53.05 Million | 61.05 Million | 82.76 Million |
| Earnings Per Share Basic | 0.27 | 0.43 | 0.71 | 0.35 | 0.40 | 0.55 |
| Earnings Per Share Diluted | 0.27 | 0.43 | 0.71 | 0.35 | 0.40 | 0.55 |
| Weighted Average Shares Outstanding | 149.13 Million | 151.2 Million | 151.2 Million | 151.2 Million | 151.2 Million | 150.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 149.13 Million | 151.2 Million | 151.2 Million | 151.2 Million | 151.2 Million | 150.48 Million |
| Gross Margin | 0.16 | 0.21 | 0.26 | 0.26 | 0.27 | 0.29 |
| EBIT Margin | 0.19 | 0.23 | 0.26 | 0.23 | 0.22 | 0.25 |
| Profit Margin | 0.04 | 0.08 | 0.13 | 0.11 | 0.12 | 0.14 |
| EBITDA | 173.19 Million | 165.79 Million | 206.7 Million | 116.43 Million | 111.17 Million | 142.08 Million |
| Earnings Before Tax Margin | 0.05 | 0.12 | 0.15 | 0.12 | 0.14 | 0.16 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 148.94 Million | 212.39 Million | 245.71 Million | 232.77 Million | 900.64 Million | 220.2 Million |
| Cost of Revenue | 114.11 Million | 171.15 Million | 193.72 Million | 199.75 Million | 756.88 Million | 189.95 Million |
| Gross Profit | 34.83 Million | 41.24 Million | 51.98 Million | 33.02 Million | 143.75 Million | 30.24 Million |
| Operating Expenses | 19.96 Million | 16.9 Million | 15.73 Million | 24.04 Million | 84.53 Million | 21.99 Million |
| Selling, General and Administrative Expenses | 35.7 Million | 12.88 Million | 13.44 Million | -19.75 Million | - | 30.92 Million |
| Research and Development Expenses | 4.73 Million | 3.21 Million | 6.61 Million | 7.8 Million | - | 5.44 Million |
| Other Expenses | -20.48 Million | -805.32 Thousand | -1.18 Million | 519.12 Thousand | -43.92 Thousand | -182.38 Thousand |
| Cost and Expenses | 134.07 Million | 188.06 Million | 209.45 Million | 223.79 Million | 841.42 Million | 211.94 Million |
| Operating Income | 9.27 Million | 24.33 Million | 25.12 Million | 4.76 Million | 44.87 Million | 5.37 Million |
| Interest Expense | 5.32 Million | 5.34 Million | 5.21 Million | 5.35 Million | 21.26 Million | 5.37 Million |
| Income Tax Expense | 508.98 Thousand | 3.07 Million | 2.89 Million | 729.57 Thousand | 4.55 Million | 42.46 Thousand |
| Earnings before Tax | 8.06 Million | 26.4 Million | 23.93 Million | 5.28 Million | 44.82 Million | 5.19 Million |
| Net Income | 7.56 Million | 23.33 Million | 21.04 Million | 4.55 Million | 40.26 Million | 5.14 Million |
| Earnings Per Share Basic | 0.05 | 0.15 | 0.14 | 0.03 | - | 0.03 |
| Earnings Per Share Diluted | 0.05 | 0.15 | 0.14 | 0.03 | - | 0.03 |
| Weighted Average Shares Outstanding | 151.2 Million | 151.2 Million | 150.33 Million | 149.73 Million | 149.13 Million | 151.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 151.2 Million | 151.2 Million | 150.33 Million | 149.73 Million | 149.13 Million | 151.2 Million |
| Gross Margin | 0.23 | 0.19 | 0.21 | 0.14 | 0.16 | 0.14 |
| EBIT Margin | 0.09 | 0.25 | 0.15 | 0.05 | - | 0.06 |
| Profit Margin | 0.05 | 0.11 | 0.09 | 0.02 | 0.04 | 0.02 |
| EBITDA | 13.39 Million | 54.14 Million | 36.97 Million | 11.6 Million | - | 12.81 Million |
| Earnings Before Tax Margin | 0.06 | 0.11 | 0.10 | 0.02 | 0.05 | 0.02 |
CLIS
ADXN
CHRTEDCA
HPIFY
688062
8961